Y Intercept Hong Kong Ltd Grows Stock Holdings in Inspire Medical Systems, Inc. $INSP

Y Intercept Hong Kong Ltd raised its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 124.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 158,274 shares of the company’s stock after acquiring an additional 87,639 shares during the quarter. Y Intercept Hong Kong Ltd owned approximately 0.55% of Inspire Medical Systems worth $8,164,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Xponance Inc. raised its stake in Inspire Medical Systems by 2.9% during the 3rd quarter. Xponance Inc. now owns 4,177 shares of the company’s stock valued at $310,000 after purchasing an additional 116 shares during the period. Daiwa Securities Group Inc. boosted its stake in Inspire Medical Systems by 38.7% in the 2nd quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock worth $60,000 after purchasing an additional 130 shares during the period. State of Wyoming grew its holdings in Inspire Medical Systems by 31.5% during the 4th quarter. State of Wyoming now owns 731 shares of the company’s stock valued at $67,000 after buying an additional 175 shares in the last quarter. Smartleaf Asset Management LLC grew its holdings in Inspire Medical Systems by 84.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after buying an additional 205 shares in the last quarter. Finally, Apollon Wealth Management LLC raised its position in shares of Inspire Medical Systems by 5.6% during the first quarter. Apollon Wealth Management LLC now owns 3,997 shares of the company’s stock valued at $206,000 after buying an additional 212 shares during the last quarter. Institutional investors own 94.91% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Summit Redstone set a $39.00 target price on shares of Inspire Medical Systems in a research report on Friday, May 22nd. Oppenheimer reiterated a “market perform” rating on shares of Inspire Medical Systems in a research note on Monday, June 15th. Robert W. Baird dropped their price objective on shares of Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Freedom Capital upgraded Inspire Medical Systems to a “strong-buy” rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. reduced their target price on Inspire Medical Systems from $67.00 to $54.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, thirteen have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Inspire Medical Systems presently has an average rating of “Hold” and an average price target of $81.05.

Inspire Medical Systems Stock Performance

Shares of INSP opened at $46.95 on Friday. The stock has a market capitalization of $1.35 billion, a PE ratio of 10.46, a P/E/G ratio of 4.75 and a beta of 0.71. The company’s fifty day moving average is $44.57 and its 200 day moving average is $62.43. Inspire Medical Systems, Inc. has a fifty-two week low of $38.91 and a fifty-two week high of $147.03.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Monday, May 4th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.28) by $0.38. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The business had revenue of $204.58 million during the quarter, compared to analyst estimates of $200.04 million. During the same quarter last year, the business earned $0.10 earnings per share. Inspire Medical Systems’s quarterly revenue was up 1.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. As a group, research analysts forecast that Inspire Medical Systems, Inc. will post 0.93 earnings per share for the current year.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.